2019 OBI Research Symposium

Attend the 2019 Ozark Biomedical Initiative Research Symposium

Researchers from Missouri S&T and Phelps Health will present their research at the annual research symposium hosted by the Ozark Biomedical Initiative (OBI) on Saturday, September. 14. The event will be held 9a.m.– 1 p.m. in the St. Pat's Ballroom of the Havener Center on the Missouri S&T campus. The event is open to the public.

Questions? Contact us at obi@mst.edu

Saturday, Sep. 14, 2019

9:00 a.m. to 1:00 p.m.
St. Pat's Ballroom, Havener Center
1346 North Bishop Avenue, Rolla, MO

Register now

Symposium Schedule

9:00 - 9:10 A.M.
Welcoming Remarks

Oral Presentations

9:10 - 9:18 A.M.

“PolyDrug Therapeutics for the Treatment of Cancer, Infectious Disease, and Traumatic Brain Injury”

Anthony Convertine

9:18 - 9:26 A.M.

“T Cell Mediated Targeted Nano Drug Delivery for Breast Cancer Treatment”

Muhammad Raisul Abedin, Kaitlyne Powers, Yongjian Liu, Sutapa Barua

9:26 - 9:34 A.M.

“AQSAR Optimized uPAR-targeted, DOX-loaded DNA Origami are Targeted, Efficient Drug Carriers in a Triple Negative Breast Cancer Model”

Natalie Holl, Brynn Shrom, Ganan Hahn, Yue-Wern Huang

9:34 - 9:42 A.M.

“Simultaneous Determination of Urinary and Serum Metabolites by UFLC-MS/MS for the Noninvasive Assessment of Traumatic Brain Injury”

Austin Sigler, Xialong He, Mousumi Bose, Alexandre Cristea, Wenyan Liu, Paul Nam, Honglan Shi, Donald James, Casey Burton

9:42 - 9:50 A.M.

“Bioprinting with Adipose Stem Cells and Polymers Modified with Bioactive Glasses for Tissue Engineering”

Krishna Kolan, Lesa Steen, August Bindbeutel, Julie Semon, Delbert Day, Ming Leu

9:50 - 9:58 A.M.

“Quantitative Determination of Pteridine Derivatives in Human Breast Cancer Cells”

Lindsey Rasmussen, Zachary Foulks, Honglan Shi, Casey Burton

9:58 - 10:06 A.M.

“Platelet Release of 5-Hydroxytryptamine with Exposure to Amniotic Fluid: An Investigation into the Pathophysiologic Mechanism of Amniotic Fluid Embolism”

Vicki Coopmans, Demitra Nichoalds, Yousra Amor, Ronald Gaddis

10:06 - 10:14 A.M.

“Broad Spectrum Antibacterial Properties of Metal-Ion Doped Borate Bioactive Glasses for Clinical Applications”

Dave Westenberg

10:14 - 10:22 A.M.

“Multifunctional CuS-nanoparticle Embedded Catheter for Multimodal Cancer Therapy”

Hiep Pham, Ed Kinzel, Chang-Soo Kim, Jonghyun Park

10:22 – 10:30 A.M.

“Community Hospital Decreases Length of Stay in Total Knee Arthroplasty Patients Utilizing Continuous Adductor Canal and
Infiltration Between the Popliteal Artery and Knee Capsule Blocks”

Michael Burns, Becky Heidotten, Emily Buckley

10:30 - 10:38 A.M.

“How Often Do Continuous Peripheral Nerve Blocks Provide 72 Hours of Pain Relief”

Michael Burns, Emily Buckley, Becky Heidotten

10:38 - 10:45 A.M.

“Continuous Bilateral Transverse Abdominis Plane Blocks Decrease Opioid Consumption by 47 Percent Following Laparoscopics
Colorectal Surgery”

Michael Burns, Emily Buckley, Becky Heidotten

10:45 - 12:00 A.M.

Poster Presentations

12:00 - 1:00 P.M.

Networking Lunch

Symposium brought to you by


Research highlights

Cancer cell nanoparticles photo by Dipak Barua

Confocal image of MDA-MB-231 breast cancer cell-internalized nanoparticles. The green spots represent nanoparticles in the cell cytoplasm. The orange and blue represent the cell plasma membrane and nucleus, respectively.  Photo credit: Dipak Barua

Want to know more?

A strategic partnership building on the success of Phelps Health and Missouri S&T,  the Ozark Biomedical Initiative (OBI) was established in July 2015 to promote collaborative research and education activities between these institutions. Learn more about OBI

Ozark Biomedical Initiative

215 Centennial Hall, 300 W. 12th Street, Rolla, MO 65409-1210
Phone: (573) 341-4689
Fax: (573) 341-4565
Email: obi@mst.edu

Operating Hours

Monday:8:00 a.m. - 4:30 p.m.
Tuesday:8:00 a.m. - 4:30 p.m.
Wednesday:8:00 a.m. - 4:30 p.m.
Thursday:8:00 a.m. - 4:30 p.m.
Friday:8:00 a.m. - 4:30 p.m.